GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
-0.03%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$207M
AUM Growth
+$207M
Cap. Flow
-$27.9M
Cap. Flow %
-13.5%
Top 10 Hldgs %
43.1%
Holding
75
New
17
Increased
13
Reduced
15
Closed
14

Top Buys

1
KRYS icon
Krystal Biotech
KRYS
$6.96M
2
IMVT icon
Immunovant
IMVT
$4.99M
3
TARS icon
Tarsus Pharmaceuticals
TARS
$4.44M
4
TSHA icon
Taysha Gene Therapies
TSHA
$4.19M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4.13M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$16.4M
2
AKRO icon
Akero Therapeutics
AKRO
$12.4M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$8.67M
4
PCVX icon
Vaxcyte
PCVX
$7.14M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
$6.13M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VRNA
51
Verona Pharma
VRNA
$9.18B
$734K 0.24%
45,000
-65,000
-59% -$1.06M
INBX
52
DELISTED
Inhibrx, Inc. Common Stock
INBX
$642K 0.21%
35,000
– –
FUSN
53
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$633K 0.21%
243,287
-169,412
-41% -$440K
ABOS icon
54
Acumen Pharmaceuticals
ABOS
$84.2M
$623K 0.2%
+150,000
New +$623K
ETNB icon
55
89bio
ETNB
$1.37B
$463K 0.15%
+30,000
New +$463K
RNA icon
56
Avidity Biosciences
RNA
$6.12B
$415K 0.14%
65,000
– –
RAIN
57
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$280K 0.09%
325,000
– –
MRSN icon
58
Mersana Therapeutics
MRSN
$34.8M
$77.8K 0.03%
61,250
– –
RETA
59
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-85,000
Closed -$8.67M
CBAY
60
DELISTED
Cymabay Therapeutics
CBAY
– –
0
– –
MORF
61
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-20,000
Closed -$1.15M
ONC
62
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
– –
-22,500
Closed -$4.01M
XBI icon
63
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
VNDA icon
64
Vanda Pharmaceuticals
VNDA
$279M
– –
-31,000
Closed -$204K
VIR icon
65
Vir Biotechnology
VIR
$765M
– –
-150,000
Closed -$3.68M
SWTX
66
DELISTED
SpringWorks Therapeutics
SWTX
– –
-27,578
Closed -$723K
REPL icon
67
Replimune Group
REPL
$460M
– –
-10,865
Closed -$252K
RCKT icon
68
Rocket Pharmaceuticals
RCKT
$358M
– –
-75,000
Closed -$1.49M
PTCT icon
69
PTC Therapeutics
PTCT
$4.41B
– –
-16,675
Closed -$678K
IOVA icon
70
Iovance Biotherapeutics
IOVA
$800M
– –
-100,000
Closed -$704K
INCY icon
71
Incyte
INCY
$17B
– –
-65,000
Closed -$4.05M
FGEN icon
72
FibroGen
FGEN
$48.4M
– –
-36,500
Closed -$98.6K
BTAI icon
73
BioXcel Therapeutics
BTAI
$52.7M
– –
0
– –
BCRX icon
74
BioCryst Pharmaceuticals
BCRX
$1.74B
– –
-200,000
Closed -$1.41M
APLS icon
75
Apellis Pharmaceuticals
APLS
$3.51B
– –
-180,000
Closed -$16.4M
1 2
3